Industry News/Patents
European Patent Received for Cancer Immunotherapy Technology
Published in Cancer Weekly, May 1st, 1995
LMI is a proprietary therapeutic approach designed to stimulate the body's own defense mechanisms against cancer cells and virus-infected cells. In pre-clinical studies, LMI has been shown to effectively stimulate and enhance the responses of cancer specific cytotoxic T lymphocytes (CTL), or "killer cells," against a variety of tumors in mice.
When combined with traditional chemotherapy, the LMI technology significantly improved survival rates of cancer-bearing mice. ...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1995-05-01)
More Articles from Cancer Weekly
- Apoptosis
bcl-2 More than an Oncogene - Biomedical Research
Difficulties Surrounding Gene Therapy Are Likely To Be Overcome - Biotherapeutics
IL-7 Gene Transfer Enhances Antitumor Immunity by Inhibiting TGF-(beta)1. - Breast Cancer/Diagnostics
Procedure Takes Less Time, Costs Thousands Less than Standard Tests - Breast Cancer/Screening
Mammography Essential for Older Women but Few Are Getting Screened - Breast Cancer/Therapy
Breast Conservation Treatment Effective for Most Cancer Patients - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
